Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin‐deficient mdx mice-Reference-Cited by-同舟云学术

Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin‐deficient mdx mice

Published:2020-12-09 Issue:1 Volume:102 Page:11-21
ISSN:0959-9673
Container-title:International Journal of Experimental Pathology
language:en
Short-container-title:Int J Exp Path

Author:

Micheletto Maria Laura Jorge¹,Hermes Tulio de Almeida¹²^ORCID,Bertassoli Bruno Machado¹^ORCID,Petri Giuliana¹,Perez Matheus Moreira³,Fonseca Fernando Luiz Affonso³,Carvalho Alzira Alves de Siqueira¹,Feder David¹

Affiliation:

1. Departament of Morphology and Physiology Medical Faculty of the ABC Santo André Brazil

2. Departament of Anatomy Federal University of Alfenas Alfenas Brazil

3. Department of Clinical Analysis Medical Faculty of the ABC Santo André Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iep.12383

Reference83 articles.

1. Evidence-based path to newborn screening for duchenne muscular dystrophy

2. Molecular Genetics of Duchenne and Becker Muscular Dystrophy

3. Cloning of the Duchenne/Becker Muscular Dystrophy Locus

4. Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle

5. Immunoelectron microscopic localization of dystrophin in myofibres

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trilobatin contributes to the improvement of myopathy in a mouse model of Duchenne muscular dystrophy;International Journal of Experimental Pathology;2024-03-13

2. Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates;Pharmaceuticals;2021-10-26

3. Genetic Modifiers and Phenotype of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis;Pharmaceuticals;2021-08-13